Stocktoria
Vir Biotechnology, Inc. VIR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-10-11
Vir Biotechnology, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 16,434,122 | $146.3M |
| CITADEL ADVISORS LLC | 2,203,876 | $19.7M |
| Point72 Asset Management, L.P. | 1,952,234 | $17.5M |
| TWO SIGMA INVESTMENTS, LP | 1,439,494 | $12.9M |
| D. E. Shaw & Co., Inc. | 817,685 | $7.3M |
| RENAISSANCE TECHNOLOGIES LLC | 761,364 | $6.8M |
| AQR CAPITAL MANAGEMENT LLC | 566,009 | $5.1M |
| MILLENNIUM MANAGEMENT LLC | 489,360 | $4.4M |
Source: SEC EDGAR filings · CIK 0001706431 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.